Naloxona [Inn-Spanish] en es it fr

Naloxona [Inn-Spanish] Brand names, Naloxona [Inn-Spanish] Analogs

Naloxona [Inn-Spanish] Brand Names Mixture

  • No information avaliable

Naloxona [Inn-Spanish] Chemical_Formula


Naloxona [Inn-Spanish] RX_link

Naloxona [Inn-Spanish] fda sheet

Naloxona [Inn-Spanish] msds (material safety sheet)

Naloxona_[Inn-Spanish] MSDS

Naloxona [Inn-Spanish] Synthesis Reference

No information avaliable

Naloxona [Inn-Spanish] Molecular Weight

327.374 g/mol

Naloxona [Inn-Spanish] Melting Point

200 - 205 oC

Naloxona [Inn-Spanish] H2O Solubility


Naloxona [Inn-Spanish] State


Naloxona [Inn-Spanish] LogP


Naloxona [Inn-Spanish] Dosage Forms


Naloxona [Inn-Spanish] Indication

For the complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics, propoxyphene, methadone and the narcotic-antagonist analgesics: nalbuphine, pentazocine and butorphanol.

Naloxona [Inn-Spanish] Pharmacology

Naloxone is an opiate antagonist and prevents or reverses the effects of opioids including respiratory depression, sedation and hypotension. Also, it can reverse the psychotomimetic and dysphoric effects of agonist-antagonists such as pentazocine. Naloxone is an essentially pure narcotic antagonist, i.e., it does not possess the "agonistic" or morphine-like properties characteristic of other narcotic antagonists; naloxone does not produce respiratory depression, psychotomimetic effects or pupillary constriction. In the absence of narcotics or agonistic effects of other narcotic antagonists, it exhibits essentially no pharmacologic activity.

Naloxona [Inn-Spanish] Absorption

Well absorbed following intramuscular injection.

Naloxona [Inn-Spanish] side effects and Toxicity

No information avaliable

Naloxona [Inn-Spanish] Patient Information

No information avaliable

Naloxona [Inn-Spanish] Organisms Affected

Humans and other mammals